메뉴 건너뛰기




Volumn 82, Issue 9, 2008, Pages 4205-4214

Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN; VIRUS PROTEIN; VIRUS PROTEIN A56;

EID: 42449122246     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02426-07     Document Type: Article
Times cited : (34)

References (47)
  • 1
    • 0029013579 scopus 로고
    • Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: Evidence for a proteoglycan-independent virus entry pathway
    • Banfield, B. W., Y. Leduc, L. Esford, K. Schubert, and F. Tufaro. 1995. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. J. Virol. 69:3290-3298.
    • (1995) J. Virol , vol.69 , pp. 3290-3298
    • Banfield, B.W.1    Leduc, Y.2    Esford, L.3    Schubert, K.4    Tufaro, F.5
  • 2
    • 24644432375 scopus 로고    scopus 로고
    • Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry
    • Bender, F. C., J. C. Whitbeck, H. Lou, G. H. Cohen, and R. J. Eisenberg. 2005. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry. J. Virol. 79:11588-11597.
    • (2005) J. Virol , vol.79 , pp. 11588-11597
    • Bender, F.C.1    Whitbeck, J.C.2    Lou, H.3    Cohen, G.H.4    Eisenberg, R.J.5
  • 3
    • 4143153933 scopus 로고    scopus 로고
    • Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b
    • Bernet, J., J. Mullick, Y. Panse, P. B. Parab, and A. Sahu. 2004. Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. J. Virol. 78:9446-9457.
    • (2004) J. Virol , vol.78 , pp. 9446-9457
    • Bernet, J.1    Mullick, J.2    Panse, Y.3    Parab, P.B.4    Sahu, A.5
  • 4
    • 1342279570 scopus 로고    scopus 로고
    • The relevance of complement to virus biology
    • Blue, C. E., O. B. Spiller, and D. J. Blackbourn. 2004. The relevance of complement to virus biology. Virology 319:176-184.
    • (2004) Virology , vol.319 , pp. 176-184
    • Blue, C.E.1    Spiller, O.B.2    Blackbourn, D.J.3
  • 5
    • 0037440764 scopus 로고    scopus 로고
    • Plasma membrane localization and fusion inhibitory activity of the cowpox virus serpin SPI-3 require a functional signal sequence and the virus encoded hemagglutinin
    • Brum, L. M., P. C. Turner, H. Devick, M. T. Baquero, and R. W. Moyer. 2003. Plasma membrane localization and fusion inhibitory activity of the cowpox virus serpin SPI-3 require a functional signal sequence and the virus encoded hemagglutinin. Virology 306:289-302.
    • (2003) Virology , vol.306 , pp. 289-302
    • Brum, L.M.1    Turner, P.C.2    Devick, H.3    Baquero, M.T.4    Moyer, R.W.5
  • 6
    • 0029360471 scopus 로고    scopus 로고
    • Carroll, M. W., and B. Moss. 1995. E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses. BioTechniques 19:352-356.
    • Carroll, M. W., and B. Moss. 1995. E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses. BioTechniques 19:352-356.
  • 7
    • 0030862430 scopus 로고    scopus 로고
    • Compact, synthetic, vaccinia virus early/late promoter for protein expression
    • Chakrabarti, S., J. R. Sisler, and B. Moss. 1997. Compact, synthetic, vaccinia virus early/late promoter for protein expression. BioTechniques 23:1094-1097.
    • (1997) BioTechniques , vol.23 , pp. 1094-1097
    • Chakrabarti, S.1    Sisler, J.R.2    Moss, B.3
  • 10
    • 0025346093 scopus 로고
    • Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization
    • Harris, S. L., I. Frank, A. Yee, G. H. Cohen, R. J. Eisenberg, and H. M. Friedman. 1990. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J. Infect. Dis. 162:331-337.
    • (1990) J. Infect. Dis , vol.162 , pp. 331-337
    • Harris, S.L.1    Frank, I.2    Yee, A.3    Cohen, G.H.4    Eisenberg, R.J.5    Friedman, H.M.6
  • 11
    • 33645768170 scopus 로고    scopus 로고
    • Herpes simplex virus type 1 and 2 glycoprotein C prevents eomplement-mediated neutralization induced by natural immunoglobulin M antibody
    • Hook, L. M., J. M. Lubinski, M. Jiang, M. K. Pangburn, and H. M. Friedman. 2006. Herpes simplex virus type 1 and 2 glycoprotein C prevents eomplement-mediated neutralization induced by natural immunoglobulin M antibody. J. Virol. 80:4038-4046.
    • (2006) J. Virol , vol.80 , pp. 4038-4046
    • Hook, L.M.1    Lubinski, J.M.2    Jiang, M.3    Pangburn, M.K.4    Friedman, H.M.5
  • 12
    • 0038785559 scopus 로고    scopus 로고
    • Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein
    • Isaacs, S. N., E. Argyropoulos, G. Sfyroera, S. Mohammad, and J. D. Lambris. 2003. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein. J. Virol. 77:8256-8262.
    • (2003) J. Virol , vol.77 , pp. 8256-8262
    • Isaacs, S.N.1    Argyropoulos, E.2    Sfyroera, G.3    Mohammad, S.4    Lambris, J.D.5
  • 13
    • 0025093977 scopus 로고
    • Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses
    • Isaacs, S. N., G. J. Kotwal, and B. Moss. 1990. Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses. Virology 178:626-630.
    • (1990) Virology , vol.178 , pp. 626-630
    • Isaacs, S.N.1    Kotwal, G.J.2    Moss, B.3
  • 14
    • 0026544083 scopus 로고
    • Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence
    • Isaacs, S. N., G. J. Kotwal, and B. Moss. 1992. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89:628-632.
    • (1992) Proc. Natl. Acad. Sci. USA , vol.89 , pp. 628-632
    • Isaacs, S.N.1    Kotwal, G.J.2    Moss, B.3
  • 16
    • 0036104834 scopus 로고    scopus 로고
    • Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection
    • Kopf, M., B. Abel, A. Gallimore, M. Carroll, and M. F. Bachmann. 2002. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Med. 8:373-378.
    • (2002) Nat. Med , vol.8 , pp. 373-378
    • Kopf, M.1    Abel, B.2    Gallimore, A.3    Carroll, M.4    Bachmann, M.F.5
  • 17
    • 0025203480 scopus 로고
    • Inhibition of the complement cascade by the major secretory protein of vaccinia virus
    • Kotwal, G. J., S. N. Isaacs, R. McKenzie, M. M. Frank, and B. Moss. 1990. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250:827-830.
    • (1990) Science , vol.250 , pp. 827-830
    • Kotwal, G.J.1    Isaacs, S.N.2    McKenzie, R.3    Frank, M.M.4    Moss, B.5
  • 18
    • 0023718738 scopus 로고
    • Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins
    • Kotwal, G. J., and B. Moss. 1988. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335:176-178.
    • (1988) Nature , vol.335 , pp. 176-178
    • Kotwal, G.J.1    Moss, B.2
  • 19
    • 33644843082 scopus 로고    scopus 로고
    • Structure and regulatory profile of the monkeypox inhibitor of complement: Comparison to homologs in vaccinia and variola and evidence for dimer formation
    • Liszewski, M. K., M. K. Leung, R. Hauhart, R. M. Buller, P. Bertram, X. Wang, A. M. Rosengard, G. J. Kotwal, and J. P. Atkinson. 2006. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J. Immunol. 176:3725-3734.
    • (2006) J. Immunol , vol.176 , pp. 3725-3734
    • Liszewski, M.K.1    Leung, M.K.2    Hauhart, R.3    Buller, R.M.4    Bertram, P.5    Wang, X.6    Rosengard, A.M.7    Kotwal, G.J.8    Atkinson, J.P.9
  • 22
    • 0026478547 scopus 로고
    • Regulation of complement activity by vaccinia virus complement-control protein
    • McKenzie, R., G. J. Kotwal, B. Moss, C. H. Hammer, and M. M. Frank. 1992. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166:1245-1250.
    • (1992) J. Infect. Dis , vol.166 , pp. 1245-1250
    • McKenzie, R.1    Kotwal, G.J.2    Moss, B.3    Hammer, C.H.4    Frank, M.M.5
  • 23
    • 33646707490 scopus 로고    scopus 로고
    • Protective immune responses against West Nile virus are primed by distinct complement activation pathways
    • Mehlhop, E., and M. S. Diamond. 2006. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203:1371-1381.
    • (2006) J. Exp. Med , vol.203 , pp. 1371-1381
    • Mehlhop, E.1    Diamond, M.S.2
  • 24
    • 19944405462 scopus 로고    scopus 로고
    • Complement activation is required for induction of a protective antibody response against West Nile virus infection
    • Mehlhop, E., K. Whitby, T. Oliphant, A. Marri, M. Engle, and M. S. Diamond. 2005. Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 79:7466-7477.
    • (2005) J. Virol , vol.79 , pp. 7466-7477
    • Mehlhop, E.1    Whitby, K.2    Oliphant, T.3    Marri, A.4    Engle, M.5    Diamond, M.S.6
  • 25
    • 29144519316 scopus 로고    scopus 로고
    • Poxvirus entry and membrane fusion
    • Moss, B. 2006. Poxvirus entry and membrane fusion. Virology 344:48-54.
    • (2006) Virology , vol.344 , pp. 48-54
    • Moss, B.1
  • 26
    • 25144504367 scopus 로고    scopus 로고
    • Identification of complement regulatory domains in vaccinia virus complement control protein
    • Mullick, J., J. Bernet, Y. Panse, S. Hallihosur, A. K. Singh, and A. Sahu. 2005. Identification of complement regulatory domains in vaccinia virus complement control protein. J. Virol. 79:12382-12393.
    • (2005) J. Virol , vol.79 , pp. 12382-12393
    • Mullick, J.1    Bernet, J.2    Panse, Y.3    Hallihosur, S.4    Singh, A.K.5    Sahu, A.6
  • 28
    • 0023691938 scopus 로고
    • Modified histogram subtraction technique for analysis of flow cytometry data
    • Overton, W. R. 1988. Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 9:619-626.
    • (1988) Cytometry , vol.9 , pp. 619-626
    • Overton, W.R.1
  • 29
    • 0026566342 scopus 로고
    • Characterization of vaccinia virus glycoproteins by monoclonal antibody preparations
    • Payne, L. G. 1992. Characterization of vaccinia virus glycoproteins by monoclonal antibody preparations. Virology 187:251-260.
    • (1992) Virology , vol.187 , pp. 251-260
    • Payne, L.G.1
  • 30
    • 0018771518 scopus 로고
    • Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus
    • Payne, L. G. 1979. Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. J. Virol. 31:147-155.
    • (1979) J. Virol , vol.31 , pp. 147-155
    • Payne, L.G.1
  • 32
    • 0032850477 scopus 로고    scopus 로고
    • Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP)
    • Rosengard, A. M., L. C. Alonso, L. C. Korb, W. M. Baldwin III, F. Sanfilippo, L. A. Turka, and J. M. Ahearn. 1999. Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). Mol. Immunol. 36:685-697.
    • (1999) Mol. Immunol , vol.36 , pp. 685-697
    • Rosengard, A.M.1    Alonso, L.C.2    Korb, L.C.3    Baldwin III, W.M.4    Sanfilippo, F.5    Turka, L.A.6    Ahearn, J.M.7
  • 33
    • 0037173003 scopus 로고    scopus 로고
    • Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement
    • Rosengard, A. M., Y. Liu, Z. Nie, and R. Jimenez. 2002. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl. Acad. Sci. USA 99:8808-8813.
    • (2002) Proc. Natl. Acad. Sci. USA , vol.99 , pp. 8808-8813
    • Rosengard, A.M.1    Liu, Y.2    Nie, Z.3    Jimenez, R.4
  • 34
    • 0032104032 scopus 로고    scopus 로고
    • Interaction of vaccinia virus complement control protein with human complement proteins: Factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway
    • Sahu, A., S. N. Isaacs, A. M. Soulika, and J. D. Lambris. 1998. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J. Immunol. 160:5596-5604.
    • (1998) J. Immunol , vol.160 , pp. 5596-5604
    • Sahu, A.1    Isaacs, S.N.2    Soulika, A.M.3    Lambris, J.D.4
  • 35
    • 0030813504 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction
    • Saifuddin, M., T. Hedayati, J. P. Atkinson, M. H. Holguin, C. J. Parker, and G. T. Spear. 1997. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J. Gen. Virol. 78:1907-1911.
    • (1997) J. Gen. Virol , vol.78 , pp. 1907-1911
    • Saifuddin, M.1    Hedayati, T.2    Atkinson, J.P.3    Holguin, M.H.4    Parker, C.J.5    Spear, G.T.6
  • 36
    • 13544260859 scopus 로고    scopus 로고
    • Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins
    • Sfyroera, G., M. Katragadda, D. Morikis, S. N. Isaacs, and J. D. Lambris. 2005. Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins. J. Immunol. 174:2143-2151.
    • (2005) J. Immunol , vol.174 , pp. 2143-2151
    • Sfyroera, G.1    Katragadda, M.2    Morikis, D.3    Isaacs, S.N.4    Lambris, J.D.5
  • 37
    • 0036932713 scopus 로고    scopus 로고
    • The formation and function of extracellular enveloped vaccinia virus
    • Smith, G. L., A. Vanderplasschen, and M. Law. 2002. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83:2915-2931.
    • (2002) J. Gen. Virol , vol.83 , pp. 2915-2931
    • Smith, G.L.1    Vanderplasschen, A.2    Law, M.3
  • 38
    • 0034037120 scopus 로고    scopus 로고
    • Smith, S. A., N. P. Mullin, J. Parkinson, S. N. Shchelkunov, A. V. Totmenin, V. N. Loparev, R. Srisatjaluk, D. N. Reynolds, K. L. Keeling, D. E. Justus, P. N. Barlow, and G. J. Kotwal. 2000. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J. Virol. 74:5659-5666.
    • Smith, S. A., N. P. Mullin, J. Parkinson, S. N. Shchelkunov, A. V. Totmenin, V. N. Loparev, R. Srisatjaluk, D. N. Reynolds, K. L. Keeling, D. E. Justus, P. N. Barlow, and G. J. Kotwal. 2000. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J. Virol. 74:5659-5666.
  • 39
    • 0037438634 scopus 로고    scopus 로고
    • Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection
    • Suresh, M., H. Molina, M. S. Salvato, D. Mastellos, J. D. Lambris, and M. Sandor. 2003. Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J. Immunol. 170:788-794.
    • (2003) J. Immunol , vol.170 , pp. 788-794
    • Suresh, M.1    Molina, H.2    Salvato, M.S.3    Mastellos, D.4    Lambris, J.D.5    Sandor, M.6
  • 40
    • 33645034664 scopus 로고    scopus 로고
    • The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells
    • Turner, P. C., and R. W. Moyer. 2006. The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells. Virology 347:88-99.
    • (2006) Virology , vol.347 , pp. 88-99
    • Turner, P.C.1    Moyer, R.W.2
  • 41
    • 0035807707 scopus 로고    scopus 로고
    • Species-specific differences in the structure of orthopoxvirus complement-binding protein
    • Uvarova, E. A., and S. N. Shchelkunov. 2001. Species-specific differences in the structure of orthopoxvirus complement-binding protein. Virus Res. 81:39-45.
    • (2001) Virus Res , vol.81 , pp. 39-45
    • Uvarova, E.A.1    Shchelkunov, S.N.2
  • 42
    • 0032560578 scopus 로고    scopus 로고
    • Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope
    • Vanderplasschen, A., E. Mathew, M. Hollinshead, R. B. Sim, and G. L. Smith. 1998. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. USA 95:7544-7549.
    • (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 7544-7549
    • Vanderplasschen, A.1    Mathew, E.2    Hollinshead, M.3    Sim, R.B.4    Smith, G.L.5
  • 43
    • 0035451351 scopus 로고    scopus 로고
    • Cutting edge: Myeloid complement C3 enhances the humoral response to peripheral viral infection
    • Verschoor, A., M. A. Brockman, D. M. Knipe, and M. C. Carroll. 2001. Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection. J. Immunol. 167:2446-2451.
    • (2001) J. Immunol , vol.167 , pp. 2446-2451
    • Verschoor, A.1    Brockman, M.A.2    Knipe, D.M.3    Carroll, M.C.4
  • 44
    • 0036214443 scopus 로고    scopus 로고
    • The role of complement in innate and adaptive immunity
    • Volanakis, J. E. 2002. The role of complement in innate and adaptive immunity. Curr. Top. Microbiol. Immunol. 266:41-56.
    • (2002) Curr. Top. Microbiol. Immunol , vol.266 , pp. 41-56
    • Volanakis, J.E.1
  • 45
    • 34249936107 scopus 로고    scopus 로고
    • Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex
    • Wagenaar, T. R., and B. Moss. 2007. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J. Virol. 81:6286-6293.
    • (2007) J. Virol , vol.81 , pp. 6286-6293
    • Wagenaar, T.R.1    Moss, B.2
  • 46
    • 0035810399 scopus 로고    scopus 로고
    • Complement. First of two parts
    • Walport, M. J. 2001. Complement. First of two parts. N. Engl. J. Med. 344:1058-1066.
    • (2001) N. Engl. J. Med , vol.344 , pp. 1058-1066
    • Walport, M.J.1
  • 47
    • 0035849176 scopus 로고    scopus 로고
    • Complement. Second of two parts
    • Walport, M. J. 2001. Complement. Second of two parts. N. Engl. J. Med. 344:1140-1144.
    • (2001) N. Engl. J. Med , vol.344 , pp. 1140-1144
    • Walport, M.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.